Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FXYD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FXYD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FXYD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LGI4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FXYD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM187B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LSR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HPN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HAMP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCN1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRAMD1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on